Physician profile
Zhao Liu
NPI 1114963394
$3,481.45
in general payments reported to CMS, 2019-2025
18 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.72 · 2021: $416 · 2022: $388 · 2023: $1,145 · 2024: $924 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,408 · Consulting Fee: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,407.69 |
| Consulting Fee | $240.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,143.85 | 2022-2025 | |
| Ucb, INC. | $493.18 | 2021-2025 | Fintepla, Briviact |
| Sk Life Science, INC. | $356.85 | 2022-2023 | |
| Immedica Pharma US, INC. | $254.37 | 2023 | |
| Sentynl Therapeutics, INC. | $240.00 | 2024 | |
| Greenwich Biosciences, INC. | $231.84 | 2021 | |
| Xeris Pharmaceuticals, INC. | $204.96 | 2023-2024 | Keveyis, Gvoke Hypopen |
| Neurelis, INC. | $123.08 | 2021 | |
| Abbvie INC. | $98.80 | 2023 | |
| Livanova USA, INC. | $71.62 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Sumitomo Pharma America, INC. | $68.62 | 2023-2024 | Aptiom |
| Cvrx, INC. | $59.44 | 2024 | Barostim Neo System |
| Sarepta Therapeutics, INC. | $50.47 | 2023 | |
| Pyros Pharmaceuticals, INC. | $31.35 | 2024 | Vigpoder |
| Biogen, INC. | $18.48 | 2023 | Spinraza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $17.16 | 2022 | |
| Zogenix INC. | $12.64 | 2021 | |
| Travere Therapeutics, INC. | $4.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhao Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.